A novel angiotensin analog with subnanomolar affinity for angiotensin- converting enzyme

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 1, 2000, Pages 260-267

  Krebs, Luke T ^a   Hanesworth, Jodie M ^a   Sardinia, Michael F ^a   Speth, Robert C ^a   Wright, John W ^a   Harding, Joseph W ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN DERIVATIVE; ANGIOTENSIN I; ANGIOTENSINOGEN DERIVATIVE; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG COMPETITION; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINS; ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; BRADYKININ; CHEMISTRY, PHYSICAL; CROSS-LINKING REAGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GUINEA PIGS; INDICATORS AND REAGENTS; IODINE RADIOISOTOPES; LUNG; MALE; PEPTIDYL-DIPEPTIDASE A; PROTEIN BINDING;

EID: 0034126373     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bao G, Gohike P, Qadri F and Unger T (1992) Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension 20:74-79.
2. Blair-West JR, Coghlan JP, Denton DA, Funder JW, Scoggins BA and Wright RD (1971) The effect of the heptapeptide (2-8) and hexapeptide (3-8) fragments of angiotensin II on aldosterone secretion. J Clin Endocrinol Metab 32:575-578.
3. Bull HG, Thornberry NA, Cordes MHJ, Patchett AA and Cordes EH (1985) Inhibition of rabbit lung angiotensin-covering enzyme by N-[(S)-1-carboxy-3-phenylpropyl]L-alanine-L-proline and N-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline. J Blol Chem 260:2952-2962.
4. Brunner HR, Waeber B and Nusserger J (1988) What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition. J Hypertens 6:S1-S5.
5. Corvol P, Michaud A, Soubrier F and Williams TA (1995) Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme. J Hypertens 13:S3-S10.
6. Cushman DW, Cheung HS, Sabo EF and Ondetti MA (1977) Design of potent competitive inhibitors of angiotensin-converting enzyme carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 16:5484-5491.
7. Cushman DW, Ondetti MA, Gordon EM, Natarajan S, Karenewsky DS, Krapcho J and Petrillo EW Jr (1987) Rational design and biochemical utility of specific inhibitors of angiotensin-converting enzyme. J Cardiotasc Pharmacol 10:S17-S30.
8. Faxon D, Creager M, Halperin J, Sussman H, Gavras H and Ryan T (1982) The effect of angiotensin converting enzyme inhibition on coronary blood flow and hemodynamics in patients without coronary artery disease. Int J Cardiol 2:251-262.
9. Fitzsinions JT (1971) The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rats' diencephalon. J Physiol Lond 214:295-303.
10. Hanesworth JM, Sardinia MF, Krebs LT, Hall KL and Harding JW (1993) Elucidation of a specific binding site for angiotensin II (3-8), angiotensin IV, in mammalian heart membranes. J Pharmacol Exp Ther 266:1036-1042.
11. Kim DH, Guinosso CJ, Buzby GC Jr, Herbst DR, McCaully RT, Wicks TC and Wendt RL (1983) (Mercaptopropanoyl)indoline-2-carboxylic acids and related compounds as potent angiotensin converting enzyme inhibitors and antihypertensive agents. J Med Chem 26:394-403.
12. Konstam MA (1995) Angiotensin converting enzyme inhibition in asymptomatic left ventricular systolic dysfunction and early heart failure. Eur Heart J 16:59-64.
13. Lowry OH, Rosbrough NJ, Farr AL and Randall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265-267.
14. Miller-Wing AV, Hanesworth JM, Sardinia MF, Wright JM, Speth RC, Grove KL and Harding JW (1993) Central angiotensin IV receptors: Distribution and specificity in guinea pig brain. J Pharmacol Exp Ther 266:1718-1726.
15. Ng KKF and Vane JR (1970) Some properties of angiotensin converting enzyme in the lung. Nature (Lond) 225:1142-1144.
16. Odya CE, Wilgis FP, Vavrek RJ and Stewart JM (1983) Interactions of kinins with angiotensin I converting enzyme (kininase II). Biochem Pharmacol 32:3839-3847.
17. Peterson GL (1977) A simplification of the protein assay method of Lowry et al which is more generally applicable. Anal Biochem 83:348-356.
18. Ripka JE, Ryan JW, Valido FA, Chung AYK, Peterson CM and Urry RL (1993) N-Glycosylation of forms of angiotensin converting enzyme from four mammalian species. Biochem Biophys Res Commun 196:503-508.
19. Rowe BP, Grove KL, Saylor DL and Speth RC (1991) Discrimination of angiotensin II receptor subtype distribution in the rat brain using non-peptide receptor antagonists. Regul Pept 33:45-53.
20. Ryan JW, Chung A, Martin LC and Ryan US (1978) New substrates for the radio-assay of angiotensin converting enzyme of endothelial cells in culture. Tissue Cell Cell 10:555-562.
21. Ryan JW, Valido FA, Chung AYK, Ripka JE, Petersen CM and Urry RL (1993) A comparison of guinea pig serum angiotensin converting enzyme with forms of angiotensin converting enzyme from human, rat, and rabbit tissues. Biochem Biophys Res Commun 196:509-514.
22. 4 receptor binding characteristics: D-amino acid and glycine-substituted peptides. Peptides 14:949-954.
23. Skeggs LT Jr, Kahn JR and Shumway NP (1956) The preparation and function of the hypertensin-converting enzyme. J Exp Med 103:295-299.
24. 2- and COOH-terminal tripeptides from luteinizing hormone-releasing hormone. Proc Natk Acad Sci USA 82:1025-1029.
25. SOLVD Investigators (1991) Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Eng J Med 328:293-302.
26. Swanson GH, Hanesworth JM, Sardinia MF, Coleman JKM, Wright JW, Hall KL, Miller-Wing AV, Stobb JW, Cook VI, Harding EC and Harding JW (1992) Discovery of a distinct binding site for angiotensin II (3-8), a putative-angiotensin IV receptor. Regul Pept 40:409-419.
27. Tonnaer JA, Weignant VM, DeJong W and DeWied D (1982) Central effects of angiotenain on drinking and blood pressure: Structure-activity relationships. Brain Res 236:417-428.
28. Wei L, Alhenc-Gelas F, Corvol P and Clauser E (1991) The two homologous domains of the human angiotensin I-converting enzyme are both catalytically active. J Biol Chem 266:9002-9008.
29. Wei L, Clauser E, Alhenc-Gelas F and Corvol P (1992) the two homologous domains of human angiotensin 1-converting enzyme interact differently with competitive inhibitors. J Biol Chem 267:13398-13405.